Unicuspid Aortic Valve in Patients Undergoing the Ross
Procedure

J 2023

Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure

GOFUS, Jan, Petr FILA, Martin VOBORNIK, Jiri ONDRASEK, Petr NĚMEC et. al.

Základní údaje

Originální název

Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure

Autoři

GOFUS, Jan (203 Česká republika), Petr FILA (203 Česká republika, garant, domácí), Martin VOBORNIK (203 Česká republika), Jiri ONDRASEK (203 Česká republika), Petr NĚMEC (203 Česká republika, domácí), Jan ŠTĚRBA (203 Česká republika, domácí), Eva CERMAKOVA (203 Česká republika), Martin TUNA (203 Česká republika) a Jan VOJACEK (203 Česká republika)

Vydání

Annals of Thoracic Surgery, New York, Elsevier Science Inc. 2023, 0003-4975

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.600 v roce 2022

Kód RIV

RIV/00216224:14110/23:00130667

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.athoracsur.2022.03.061

UT WoS

000944472800001

Klíčová slova anglicky

Unicuspid Aortic Valve; Ross Procedure

Štítky

14110911, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 27. 4. 2023 13:31, Mgr. Tereza Miškechová

Anotace

V originále

BACKGROUND The prevalence and outcomes of the unicuspid aortic valve (UAV) in patients undergoing the Ross procedure have been strongly underreported in the current literature. We sought to evaluate this in comparison with bicuspid (BAV) and tricuspid valve (TAV) in our Ross cohort.METHODS This was a retrospective observational study of patients undergoing the Ross procedure at 2 dedicated centers between 2009 and 2020. Primary end points were the risks of midterm autograft reoperation and the onset of at least moderate aortic regurgitation during follow-up. The secondary end point was to compare the perioperative out-comes between the groups.RESULTS Included in the analysis were 286 patients, of those 39% with UAV, 52% with BAV, and 9% with TAV. UAV patients were operated on at the youngest age (P < .001) and more often for a combined hemodynamic aortic valve pathology (P = .02). They had the largest aortic root dimensions: annulus (P = .01), Valsalva sinuses (P = .11), sino-tubular junction (P = .001), and ascending aorta (P < .0001). The risks of reoperation (P = .86) and the onset of aortic regurgitation (P = .75) were comparable among the groups over the follow-up of 4.1 years. There was no difference in perioperative outcomes.CONCLUSIONS UAV is a separate unit characterized by a distinct hemodynamic pathology and generated aortopathy. It is not associated with a higher risk of reoperation or new onset of aortic regurgitation after the Ross procedure in the midterm postoperatively. At the current state, UAV remains acceptable for the Ross procedure.

Citovat

GOFUS, Jan, Petr FILA, Martin VOBORNIK, Jiri ONDRASEK, Petr NĚMEC, Jan ŠTĚRBA, Eva CERMAKOVA, Martin TUNA a Jan VOJACEK. Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure. Annals of Thoracic Surgery. New York: Elsevier Science Inc., 2023, roč. 115, č. 3, s. 626-631. ISSN 0003-4975. Dostupné z: https://dx.doi.org/10.1016/j.athoracsur.2022.03.061.

@article{2278239,
   author = {Gofus, Jan and Fila, Petr and Vobornik, Martin and Ondrasek, Jiri and Němec, Petr and Štěrba, Jan and Cermakova, Eva and Tuna, Martin and Vojacek, Jan},
   article_location = {New York},
   article_number = {3},
   doi = {http://dx.doi.org/10.1016/j.athoracsur.2022.03.061},
   keywords = {Unicuspid Aortic Valve; Ross Procedure},
   language = {eng},
   issn = {0003-4975},
   journal = {Annals of Thoracic Surgery},
   title = {Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure},
   url = {https://www.sciencedirect.com/science/article/abs/pii/S0003497522005124?via%3Dihub},
   volume = {115},
   year = {2023}
}

TY  - JOUR
ID  - 2278239
AU  - Gofus, Jan - Fila, Petr - Vobornik, Martin - Ondrasek, Jiri - Němec, Petr - Štěrba, Jan - Cermakova, Eva - Tuna, Martin - Vojacek, Jan
PY  - 2023
TI  - Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure
JF  - Annals of Thoracic Surgery
VL  - 115
IS  - 3
SP  - 626-631
EP  - 626-631
PB  - Elsevier Science Inc.
SN  - 00034975
KW  - Unicuspid Aortic Valve
KW  - Ross Procedure
UR  - https://www.sciencedirect.com/science/article/abs/pii/S0003497522005124?via%3Dihub
N2  - BACKGROUND The prevalence and outcomes of the unicuspid aortic valve (UAV) in patients undergoing the Ross procedure have been strongly underreported in the current literature. We sought to evaluate this in comparison with bicuspid (BAV) and tricuspid valve (TAV) in our Ross cohort.METHODS This was a retrospective observational study of patients undergoing the Ross procedure at 2 dedicated centers between 2009 and 2020. Primary end points were the risks of midterm autograft reoperation and the onset of at least moderate aortic regurgitation during follow-up. The secondary end point was to compare the perioperative out-comes between the groups.RESULTS Included in the analysis were 286 patients, of those 39% with UAV, 52% with BAV, and 9% with TAV. UAV patients were operated on at the youngest age (P < .001) and more often for a combined hemodynamic aortic valve pathology (P = .02). They had the largest aortic root dimensions: annulus (P = .01), Valsalva sinuses (P = .11), sino-tubular junction (P = .001), and ascending aorta (P < .0001). The risks of reoperation (P = .86) and the onset of aortic regurgitation (P = .75) were comparable among the groups over the follow-up of 4.1 years. There was no difference in perioperative outcomes.CONCLUSIONS UAV is a separate unit characterized by a distinct hemodynamic pathology and generated aortopathy. It is not associated with a higher risk of reoperation or new onset of aortic regurgitation after the Ross procedure in the midterm postoperatively. At the current state, UAV remains acceptable for the Ross procedure.
ER  -

GOFUS, Jan, Petr FILA, Martin VOBORNIK, Jiri ONDRASEK, Petr NĚMEC, Jan ŠTĚRBA, Eva CERMAKOVA, Martin TUNA a Jan VOJACEK. Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure. \textit{Annals of Thoracic Surgery}. New York: Elsevier Science Inc., 2023, roč.~115, č.~3, s.~626-631. ISSN~0003-4975. Dostupné z: https://dx.doi.org/10.1016/j.athoracsur.2022.03.061.

Podrobný výpis o publikaci